netFormulary North Central London NHS
Joint Formulary  
 Search
 Formulary Chapter 4: Central nervous system - Full Chapter
Chapter Links...
 Details...
04.07.04.01  Expand sub section  Treatment of the acute migraine attack
04.07.04.01  Expand sub section  Analgesics
04.07.04.01  Expand sub section  5HT1 agonists
Sumatriptan
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Secondary care notes

  • NMUH approvals:
    • Only injection and generic tablets are on formulary
  • RFL approvals:
    • Restricted to neurologists and only for in-patient prescribing
    • The nasal spray is not formulary.
  • RNOH approvals:
    • Nil
  • UCLH approvals:
  • WH approvals:
    • First line: Tablets
    • Second line: Nasal spray
    • Third line: Injection
 
   
Zolmitriptan
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
AAAAAAAA

Secondary care notes

  • NMUH approvals:
    • Not applicable
  • RFL approvals:
    • Restricted to neurologists
  • RNOH approvals:
    • Not applicable
  • UCLH approvals:
  • WH approvals:
    • Not applicable
 
   
04.07.04.01  Expand sub section  Ergot alkaloids
04.07.04.01  Expand sub section  Anti-emetics to top
04.07.04.01  Expand sub section  Other drugs for migrane
 ....
 Non Formulary Items
Almotriptan

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Eletriptan

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Frovatriptan

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Naratriptan

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Rizatriptan

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

GP - 1st

Medicines suitable for first-line use within primary care.

Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing. 

  

GP - 2nd

Medicines suitable for second-line use within primary care.

Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing. 

  

GP - Amber

Medicines that should be initiated by a specialist. Prescribing can be transferred to primary care once the patient has been stabilised.  

Shared care: For drugs with regular, ongoing need for monitoring and/or assessment of efficacy or toxicity. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the North Central London JFC.

Fact sheet: For drugs with some concerns surrounding safety or efficacy but do not require regular monitoring and/or monitoring of effectiveness/toxicity.

  

GP - Red

Medicines which should normally be prescribed by specialists only (hospital only).

For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.

  

GP - Grey

Medicines on hospital formularies which have not been reviewed for suitability in primary care.  

Black

Medicines not recommended for routine use in primary or secondary care.

Medicines, which the North Central London JFC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.

  

netFormulary